Figure 7From: Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapyProgression-free survival according to ERCC1 expression which was based on platinum chemotherapy (more than 42.6 vs. 13.0 months, P = 0.001).Back to article page